UBS Group’s Salarius Pharmaceuticals SLRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.3K | Sell |
1,209
-1,045
| -46% | -$14K | ﹤0.01% | 7263 |
|
2025
Q1 | $25.5K | Buy |
2,254
+1,782
| +378% | +$20.2K | ﹤0.01% | 6756 |
|
2024
Q4 | $13K | Buy |
472
+455
| +2,676% | +$12.6K | ﹤0.01% | 6933 |
|
2024
Q3 | $375 | Buy |
17
+9
| +113% | +$199 | ﹤0.01% | 7753 |
|
2024
Q2 | $269 | Buy |
+8
| New | +$269 | ﹤0.01% | 7854 |
|
2024
Q1 | – | Sell |
-1
| Closed | -$51 | – | 7925 |
|
2023
Q4 | $51 | Hold |
1
| – | – | ﹤0.01% | 7777 |
|
2023
Q3 | $51 | Hold |
1
| – | – | ﹤0.01% | 7850 |
|
2023
Q2 | $116 | Sell |
1
-8
| -89% | -$928 | ﹤0.01% | 7399 |
|
2023
Q1 | $2.15K | Buy |
9
+7
| +350% | +$1.67K | ﹤0.01% | 7465 |
|
2022
Q4 | $366 | Sell |
2
-12
| -86% | -$2.2K | ﹤0.01% | 9021 |
|
2022
Q3 | $8K | Hold |
14
| – | – | ﹤0.01% | 7645 |
|
2022
Q2 | $9K | Buy |
14
+13
| +1,300% | +$8.36K | ﹤0.01% | 7127 |
|
2022
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 8861 |
|
2021
Q4 | $1K | Sell |
1
-1
| -50% | -$1K | ﹤0.01% | 8899 |
|
2021
Q3 | $7K | Hold |
2
| – | – | ﹤0.01% | 7178 |
|
2021
Q2 | $7K | Sell |
2
-2
| -50% | -$7K | ﹤0.01% | 7244 |
|
2021
Q1 | $19K | Buy |
+4
| New | +$19K | ﹤0.01% | 6423 |
|
2020
Q2 | – | Sell |
-4
| Closed | -$8K | – | 7291 |
|
2020
Q1 | $8K | Buy |
+4
| New | +$8K | ﹤0.01% | 6172 |
|
2019
Q4 | – | Sell |
-1
| Closed | -$17K | – | 6682 |
|
2019
Q3 | $17K | Buy |
+1
| New | +$17K | ﹤0.01% | 5872 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 7125 |
|
2019
Q1 | – | Sell |
-1
| Closed | -$13K | – | 7090 |
|
2018
Q4 | $13K | Buy |
+1
| New | +$13K | ﹤0.01% | 6178 |
|
2018
Q3 | – | Hold |
0
| – | -$1K | – | 7161 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 6900 |
|
2018
Q1 | – | Hold |
0
| – | -$7K | – | 7048 |
|
2017
Q4 | – | Hold |
0
| – | -$6K | – | 6264 |
|
2017
Q3 | – | Hold |
0
| – | -$13K | – | 6235 |
|
2017
Q2 | – | Hold |
0
| – | -$18K | – | 5662 |
|
2017
Q1 | – | Hold |
0
| – | -$9K | – | 5298 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 6025 |
|
2016
Q3 | – | Hold |
0
| – | -$21K | – | 6828 |
|
2016
Q2 | – | Hold |
0
| – | – | – | 5392 |
|
2016
Q1 | – | Hold |
0
| – | -$17K | – | 6845 |
|
2015
Q4 | – | Hold |
0
| – | -$30K | – | 5686 |
|
2015
Q3 | – | Hold |
0
| – | – | – | 5103 |
|
2015
Q2 | – | Hold |
0
| – | -$24K | – | 6867 |
|
2015
Q1 | – | Hold |
0
| – | – | – | 5241 |
|